Perez-Altozano, J. (Javier)

Filtering

20211

Settings

Author search.filters.isAuthorOfPublication.3fe1072d-acfe-4efd-81f2-ee6749695545

Search Results

Now showing 1 - 1 of 1
  • Thumbnail Image
    SEOM clinical guidelines for anaemia treatment in cancer patients (2020)
    (Springer Nature, 2021) Escobar-Álvarez, Y. (Yolanda); Peñas, R. (Ramón) de las; Perez-Altozano, J. (Javier); Ros-Martínez, S. (Silverio); Sabino-Álvarez, A. (Araceli); Blasco-Cordellat, A. (Ana); Brozos-Vázquez, E. (Elena); Corral-Jaime, J. (Jesús); García-Escobar, I. (Ignacio); Beato-Zambrano, C. (Carmen)
    Anaemia is defned by the presence of haemoglobin (Hb) levels<13 g/dL in men and 12 g/dL in women. Up to 39% of cancer patients present it at the time of diagnosis and up to 40% have iron defciency. Anaemia causes fatigue, functional deterioration and a reduction in the quality of life; it has also been associated with a poorer response to anti-tumour treatment and lower survival. Basic diagnostic tests for anaemia are simple and should be a routine part of clinical practice. These guidelines review the available evidence on the use of diferent therapies for treating anaemia: erythropoiesis-stimulating agents, iron supplements, and transfusion of blood products.